Mini Curriculum Vitae

VERRIER Bernard
Bernard VERRIER

Equipe : Vecteurs colloïdaux et ingénierie thérapeutique ciblée
Courriel : bernard.verrier@ibcp.fr
Téléphone : +33(0)4-72-72-26-36
Statut : Directeur de recherches

125 publications au total. Seules les 5 dernières années sont affichées

2022
125.  Aqueous suspensions of Fuller's earth potentiate the adsorption capacities of paraoxon and improve skin decontamination properties. 
Danoy A, Durmaz K, Paoletti M, Vachez L, Roul A, Sohier J, Verrier B
(2022) J Hazard Mater 425 :127714-127714  Icon PUBMED

2021
124.  Latent TGF-β Activation Is a Hallmark of the Tenascin Family. 
Aubert A, Mercier-gouy P, Aguero S, Berthier L, Liot S, Prigent L, Alcaraz Lb, Verrier B, Terreux R, Moali C, Lambert E, Valcourt U
(2021) Front Immunol 12 :613438-613438  Icon PUBMED

123.  LipoParticles: Lipid-Coated PLA Nanoparticles Enhanced In Vitro mRNA Transfection Compared to Liposomes. 
Ayad C, Libeau P, Lacroix-gimon C, Ladavière C, Verrier B
(2021) Pharmaceutics 13 :  Icon PUBMED

122.  Surface charge modulation of rifampicin-loaded PLA nanoparticles to improve antibiotic delivery in Staphylococcus aureus biofilms. 
Da Costa D, Exbrayat-héritier C, Rambaud B, Megy S, Terreux R, Verrier B, Primard C
(2021) J Nanobiotechnology 19 :12-12  Icon PUBMED

121.  Seaweed Sulfated Polysaccharides against Respiratory Viral Infections. 
Jabeen M, Dutot M, Fagon R, Verrier B, Monge C
(2021) Pharmaceutics 13 :  Icon PUBMED

120.  Combining an optimized mRNA template with a double purification process allows strong expression of in vitro transcribed mRNA. 
Linares-fernández S, Moreno J, Lambert E, Mercier-gouy P, Vachez L, Verrier B, Exposito Jy
(2021) Mol Ther Nucleic Acids 26 :945-956  Icon PUBMED

119.  Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins. 
Liot S, Balas J, Aubert A, Prigent L, Mercier-gouy P, Verrier B, Bertolino P, Hennino A, Valcourt U, Lambert E
(2021) Front Immunol 12 :612271-612271  Icon PUBMED

118.  Development of thymic tumor in [LSL:KrasG12D; Pdx1-CRE] mice, an adverse effect associated with accelerated pancreatic carcinogenesis. 
Liot S, El Kholti N, Balas J, Genestier L, Verrier B, Valcourt U, Lambert E
(2021) Sci Rep 11 :15075-15075  Icon PUBMED

117.  Sublingual antigen delivery: a solution for needle-free HIV vaccination. 
Monge C, Verrier B
(2021) Expert Rev Vaccines 20 :1047-1050  Icon PUBMED

116.  Autophagy and Mitophagy-Related Pathways at the Crossroads of Genetic Pathways Involved in Familial Sarcoidosis and Host-Pathogen Interactions Induced by Coronaviruses. 
Pacheco Y, Valeyre D, El Jammal T, Vallee M, Chevalier F, Lamartine J, Sigaudo-roussel D, Verrier B, Israel-biet D, Freymond N, Cottin V, Calender A
(2021) Cells 10 :  Icon PUBMED

115.  Sublingual protein delivery by a mucoadhesive patch made of natural polymers. 
Paris Al, Caridade S, Colomb E, Bellina M, Boucard E, Verrier B, Monge C
(2021) Acta Biomater 128 :222-235  Icon PUBMED

114.  Sublingual vaccination and delivery systems. 
Paris Al, Colomb E, Verrier B, Anjuère F, Monge C
(2021) J Control Release 332 :553-562  Icon PUBMED

113.  Biodistribution of surfactant-free poly(lactic-acid) nanoparticles and uptake by endothelial cells and phagocytes in zebrafish: Evidence for endothelium to macrophage transfer. 
Rességuier J, Levraud Jp, Dal Nk, Fenaroli F, Primard C, Wohlmann J, Carron G, Griffiths Gw, Le Guellec D, Verrier B
(2021) J Control Release 331 :228-245  Icon PUBMED

2020
112.  Development of an antibacterial nanocomposite hydrogel for human dental pulp engineering. 
Bekhouche M, Bolon M, Charriaud F, Lamrayah M, Da Costa D, Primard C, Costantini A, Pasdeloup M, Gobert S, Mallein-gerin F, Verrier B, Ducret M, Farges Jc
(2020) J Mater Chem B 8 :8422-8432  Icon PUBMED

111.  Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker. 
Liot S, Aubert A, Hervieu V, Kholti Ne, Schalkwijk J, Verrier B, Valcourt U, Lambert E
(2020) Matrix Biol Plus 6-7 :100021-100021  Icon PUBMED

110.  Molecular Dynamics Studies of Poly(Lactic Acid) Nanoparticles and Their Interactions with Vitamin E and TLR Agonists Pam1CSK4 and Pam3CSK4. 
Megy S, Aguero S, Da Costa D, Lamrayah M, Berthet M, Primard C, Verrier B, Terreux R
(2020) Nanomaterials (basel) 10 :  Icon PUBMED

2019
109.  Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation. 
Coolen Al, Lacroix C, Mercier-gouy P, Delaune E, Monge C, Exposito Jy, Verrier B
(2019) Biomaterials 195 :23-37  Icon PUBMED

108.  Molecular modelling of TLR agonist Pam(3)CSK(4) entrapment in PLA nanoparticles as a tool to explain loading efficiency and functionality. 
Lamrayah M, Charriaud F, Hu S, Megy S, Terreux R, Verrier B
(2019) Int J Pharm 568 :118569-118569  Icon PUBMED

107.  Tailoring mRNA Vaccine to Balance Innate/Adaptive Immune Response. 
Linares-fernandez S, Lacroix C, Exposito Jy, Verrier B
(2019) Trends Mol Med  :  Icon PUBMED

2017
106.  Tuning the Hydrophilic/Hydrophobic Balance to Control the Structure of Chitosan Films and Their Protein Release Behavior. 
Becerra J, Sudre G, Royaud I, Montserret R, Verrier B, Rochas C, Delair T, David L
(2017) Aaps Pharmscitech 18 :1070-1083  Icon PUBMED

105.  Nanoparticle-Based Dressing: The Future of Wound Treatment? 
Berthet M, Gauthier Y, Lacroix C, Verrier B, Monge C
(2017) Trends Biotechnol 35 :770-784  Icon PUBMED

104.  Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles. 
Boisgard As, Lamrayah M, Dzikowski M, Salmon D, Kirilov P, Primard C, Pirot F, Fromy B, Verrier B
(2017) Eur J Pharm Biopharm 116 :51-60  Icon PUBMED

103.  Antibiotic incorporation in jet-sprayed nanofibrillar biodegradable scaffolds for wound healing. 
Dzikowski M, Castanie N, Guedon A, Verrier B, Primard C, Sohier J
(2017) Int J Pharm  :  Icon PUBMED

102.  Neutralizing and Targeting Properties of a New Set of α4β7-Specific Antibodies Are Influenced by Their Isotype. 
Girard A, Jelicic K, Van Ryk D, Rochereau N, Cicala C, Arthos J, Noailly B, Genin C, Verrier B, Laurant S, Razanajaoana-doll D, Pin Jj, Paul S
(2017) J Acquir Immune Defic Syndr 75 :118-127  Icon PUBMED

101.  Cutting Edge: A Dual TLR2 and TLR7 Ligand Induces Highly Potent Humoral and Cell-Mediated Immune Responses. 
Gutjahr A, Papagno L, Nicoli F, Lamoureux A, Vernejoul F, Lioux T, Gostick E, Price Da, Tiraby G, Perouzel E, Appay V, Verrier B, Paul S
(2017) J Immunol 198 :4205-4209  Icon PUBMED

100.  Improving bioassay sensitivity through immobilization of bio-probes onto reactive micelles. 
Jimenez-sanchez G, Terrat C, Verrier B, Gigmes D, Trimaille T
(2017) Chem Commun (camb) 53 :8062-8065  Icon PUBMED

99.  Critical role for skin-derived migratory DCs and Langerhans cells in TFH and GC responses after intradermal immunization. 
Levin C, Bonduelle O, Nuttens C, Primard C, Verrier B, Boissonnas A, Combadiere B
(2017) J Invest Dermatol 0 :0  Icon PUBMED

98.  Specific and Efficient Uptake of Surfactant-Free Poly(Lactic Acid) Nanovaccine Vehicles by Mucosal Dendritic Cells in Adult Zebrafish after Bath Immersion. 
Resseguier J, Delaune E, Coolen Al, Levraud Jp, Boudinot P, Le Guellec D, Verrier B
(2017) Front Immunol 8 :190-190  Icon PUBMED

97.  Comparison of four different fuller's earth formulations in skin decontamination. 
Roul A, Le Ca, Gustin Mp, Clavaud E, Verrier B, Pirot F, Falson F
(2017) J Appl Toxicol  :  Icon PUBMED

96.  Exploiting Natural Cross-reactivity between Human Immunodeficiency Virus (HIV)-1 p17 Protein and Anti-gp41 2F5 Antibody to Induce HIV-1 Neutralizing Responses In Vivo. 
Verrier B, Paul S, Terrat C, Bastide L, Ensinas A, Phelip C, Chanut B, Bulens-grassigny L, Jospin F, Guillon C
(2017) Front Immunol 8 :770-770  Icon PUBMED

95.  Ternary polysaccharide complexes: Colloidal drug delivery systems stabilized in physiological media. 
Wu D, Ensinas A, Verrier B, Cuvillier A, Champier G, Paul S, Delair T
(2017) Carbohydr Polym 172 :265-274  Icon PUBMED